中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2013年
5期
619-621
,共3页
邹宏运%李元海%张海涅%邬微微%陈珂
鄒宏運%李元海%張海涅%鄔微微%陳珂
추굉운%리원해%장해열%오미미%진가
磷酸肌酸%再灌注损伤%肝%预先给药
燐痠肌痠%再灌註損傷%肝%預先給藥
린산기산%재관주손상%간%예선급약
Phosphocreatine%Reperfusion injury%Liver%Pretreatment
目的 评价不同剂量磷酸肌酸钠预先给药对大鼠肝缺血再灌注损伤的影响.方法 健康雄性SD大鼠30只,体重200~250 g,采用随机数字表法分为5组(n=6):假手术组(S组)、缺血再灌注组(I/R组)、不同剂量磷酸肌酸钠预先给药组(P1~3组).采用阻断肝左中动脉及其门静脉90 min恢复灌注的方法制备大鼠肝缺血再灌注模型.P1-3组于缺血前60 min时分别尾静脉注射磷酸肌酸钠50、150和4S0mg/kg.S组和I/R组给予等容量生理盐水.于再灌注4h时采集腹主动脉血样,测定血浆ALT、AST、TNF-α和IL-1β水平.取肝组织,采用ELISA法检测MPO活性,免疫组化法检测细胞间粘附分子(ICAM-1)的表达水平,TUNEL法检测肝细胞凋亡数,电镜下观察病理学结果.结果 与S组比较,I/R组和P1~3组肝组织MPO、血浆ALT、AST活性及TNF-α、IL-1β浓度、肝细胞凋亡数升高(P<0.05);与I/R组比较,P1~3组上述指标降低(P<0.05);P1~3组上述指标依次降低(P<0.05).结论 磷酸肌酸钠预先给药可呈剂量依赖性地减轻大鼠肝缺血再灌注损伤,其机制与抑制炎性反应有关.
目的 評價不同劑量燐痠肌痠鈉預先給藥對大鼠肝缺血再灌註損傷的影響.方法 健康雄性SD大鼠30隻,體重200~250 g,採用隨機數字錶法分為5組(n=6):假手術組(S組)、缺血再灌註組(I/R組)、不同劑量燐痠肌痠鈉預先給藥組(P1~3組).採用阻斷肝左中動脈及其門靜脈90 min恢複灌註的方法製備大鼠肝缺血再灌註模型.P1-3組于缺血前60 min時分彆尾靜脈註射燐痠肌痠鈉50、150和4S0mg/kg.S組和I/R組給予等容量生理鹽水.于再灌註4h時採集腹主動脈血樣,測定血漿ALT、AST、TNF-α和IL-1β水平.取肝組織,採用ELISA法檢測MPO活性,免疫組化法檢測細胞間粘附分子(ICAM-1)的錶達水平,TUNEL法檢測肝細胞凋亡數,電鏡下觀察病理學結果.結果 與S組比較,I/R組和P1~3組肝組織MPO、血漿ALT、AST活性及TNF-α、IL-1β濃度、肝細胞凋亡數升高(P<0.05);與I/R組比較,P1~3組上述指標降低(P<0.05);P1~3組上述指標依次降低(P<0.05).結論 燐痠肌痠鈉預先給藥可呈劑量依賴性地減輕大鼠肝缺血再灌註損傷,其機製與抑製炎性反應有關.
목적 평개불동제량린산기산납예선급약대대서간결혈재관주손상적영향.방법 건강웅성SD대서30지,체중200~250 g,채용수궤수자표법분위5조(n=6):가수술조(S조)、결혈재관주조(I/R조)、불동제량린산기산납예선급약조(P1~3조).채용조단간좌중동맥급기문정맥90 min회복관주적방법제비대서간결혈재관주모형.P1-3조우결혈전60 min시분별미정맥주사린산기산납50、150화4S0mg/kg.S조화I/R조급여등용량생리염수.우재관주4h시채집복주동맥혈양,측정혈장ALT、AST、TNF-α화IL-1β수평.취간조직,채용ELISA법검측MPO활성,면역조화법검측세포간점부분자(ICAM-1)적표체수평,TUNEL법검측간세포조망수,전경하관찰병이학결과.결과 여S조비교,I/R조화P1~3조간조직MPO、혈장ALT、AST활성급TNF-α、IL-1β농도、간세포조망수승고(P<0.05);여I/R조비교,P1~3조상술지표강저(P<0.05);P1~3조상술지표의차강저(P<0.05).결론 린산기산납예선급약가정제량의뢰성지감경대서간결혈재관주손상,기궤제여억제염성반응유관.
Objective To evaluate the effects of pretreatment with different doses of phosphocreatine on hepatic ischemia-repeffusion (I/R) injury in rats.Methods.Thirty male Sprague-Dawley rats,weighing 200-250 g,were randomly divided into 5 groups (n =6 each):sham operation group (group S),hepatic I/R group (group I/R),and pretreatment with different doses of phosphocreatine groups (groups P1-3).Hepatic I/R was induced by 90 min occlusion of the hepatic artery and portal vein entering the middle and left lobes of the liver followed by 4 h reperfusion in anesthetized rats.Phosphocreatine 50,150 and 450 mg/kg were injected via the tail vein at 60 min before ischemia in groups P1-3,respectively.In groups S and I/R,the equal volume of normal saline was given instead.Blood samples were taken from the abdominal aorta at 4 h of reperfusion for determination of plasma alanine aminotransferase (ALT),aspartate aminotransferase (AST),TNF-α and IL-1β concentrations.The rats were then sacrificed and the livers were removed for determination of myeloperoxidase (MPO) activity (by ELISA),intercellular adhesion molecule-1 (ICAM-1) expression (by immunohistochemistry),and cell apoptosis (by TUNEL) and for microscopic examination (by electron microscopy).Results The MPO activity in liver tissues,plasma ALT and AST activities,TNF-α and IL-1β concentrations and the number of apoptotic cells were significantly higher in groups I/R and P1-3 than in group S,while lower in groups P1-3 than in group I/R (P < 0.05).The parameters mentioned above were decreasedin turn in groups P1-3 (P < 0.05).Conclusion Phosphocreatine pretreatment can attenuate the hepatic I/R injury in rats in a dose-dependent manner and inhibition of the inflammatory responses is involved in the mechanism.